Homepage > Company > Media > Pharma News > 2021 > Congo confirms three new Ebola cases

Congo confirms three new Ebola cases

GOMA, Democratic Republic of Congo (Reuters) - Three new cases of Ebola have been confirmed in eastern Democratic Republic of Congo, bringing to 11 the number of cases since authorities declared a resurgence of the virus last month.

The new cases were detected in the Butembo health zone, the health minister of North Kivu province, Eugene Nzanzu Salita, told reporters.

The cases represent a flare-up of the 2018-20 epidemic, which killed more than 2,200 people before it was declared over last June. Four people have died and two have recovered among the 11 cases, Nzanzu said.

Congo has experienced 11 outbreaks since the virus was first discovered near the Ebola River in 1976, more than double any other country.

MARCH 1, 2021

https://www.reuters.com/

Read also

Spinogenix’s ALS hopeful to advance to registrational trial

Spinogenix’s first-in-class ALS treatment, SPG302 has been shown to slow disease progression in 82% of patients during a Phase IIa study.

FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency

Thymidine kinase 2 deficiency (TK2d) is an ultra-rare (1.64 cases per 1,000,000 people) often fatal, genetic mitochondrial disease characterized by progressive and severe muscle weakne...

Cencora

Cencora to invest $1bn in US pharma distribution network

Celltrion

Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates